1100748-84-2 Usage
Description
1-Amino-7-azaspiro[3.5]nonane-7-carboxylic acid tert-butyl ester is an organic compound featuring a unique spiro scaffold structure, which is a key component in the development of various pharmaceuticals and bioactive molecules. Its chemical properties allow for further functionalization and modification, making it a versatile building block in the field of drug discovery and design.
Uses
Used in Pharmaceutical Industry:
1-Amino-7-azaspiro[3.5]nonane-7-carboxylic acid tert-butyl ester is used as a synthetic reagent for the development of novel bioactive molecules and drug candidates. Its unique spiro scaffold structure provides a foundation for the creation of new compounds with potential therapeutic applications.
Used in Drug Discovery:
1-Amino-7-azaspiro[3.5]nonane-7-carboxylic acid tert-butyl ester is used as a key intermediate in the synthesis of a series of spiro scaffolds, which are essential for the identification and development of new drugs with improved efficacy and selectivity. The compound's versatility in chemical modifications enables the exploration of various structural variations, leading to the discovery of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1100748-84-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,0,7,4 and 8 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1100748-84:
(9*1)+(8*1)+(7*0)+(6*0)+(5*7)+(4*4)+(3*8)+(2*8)+(1*4)=112
112 % 10 = 2
So 1100748-84-2 is a valid CAS Registry Number.
1100748-84-2Relevant articles and documents
ION CHANNEL INHIBITORY COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USES
-
Paragraph 00278; 00279, (2017/06/07)
The present invention is directed towards new chemical entities which primarily inhibit the human T-type calcium channels and differentially modulate other key ion channels to control cell excitability, and abnormal neuronal activity particularly involved in the development and maintenance of persistent or chronic pain, and / or neurological disorders. These novel compounds are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which these ion channels are involved. The invention is also directed towards pharmaceutical formulations comprising these compounds and the uses of these compounds.
